Speech Buddies, Inc.: A Confidential Sale to a Strategic Medical-Products Acquirer

Speech Buddies, Inc.

Pediatric Speech-Therapy Technology & Medical Devices | San Francisco, California

A Patent-Protected Pediatric Therapy Platform Built Around Better Outcomes

Speech Buddies, Inc. was founded by mechanical engineer Alexey Salamini and practicing speech-language pathologist Gordy Rogers to create a better way to teach children correct articulation.

Together, they developed patent-protected intraoral tactile-biofeedback tools that allow children to feel, rather than simply hear, the correct tongue placement for the five sounds most commonly involved in childhood articulation disorders: R, S, L, CH, and SH.

The company built a first-in-class position in pediatric speech-therapy technology, serving Speech-Language Pathologists in school and clinical environments as well as families reinforcing therapy at home. Its Speech Buddies Connect marketplace also linked parents with a nationwide network of more than 7,000 ASHA-certified speech-language pathologists.

Finding a New Steward to Reinvigorate a Founder-Built Brand

By the time Speech Buddies came to market, its founders had moved on to other professional endeavors and were no longer active in day-to-day operations.

Rather than wind the business down or sell simply to the first available buyer, ownership wanted a new steward with the resources and motivation to reinvigorate the brand, expand its reach, and carry forward the company's mission of helping more children and families.

Focused Outreach to Buyers Who Understood the Mission

With the transaction led by Dealmaker Raquel Wilson, Sunbelt Atlanta built a targeted buyer universe spanning pediatric healthcare, medical products, and consumer-health technology.

Over a 5.5-month process, the engagement reached 27 qualified buyers under strict confidentiality, protecting Speech Buddies' brand, customer relationships, and competitive position throughout the marketing period.

The process ultimately converged on one highly aligned letter of intent. In this transaction, precision mattered more than raw bid volume: the right buyer already had an adjacent pediatric healthcare platform and a clear strategic rationale for owning Speech Buddies.

Protected IP, Documented Systems, and Clinical Proof

Speech Buddies entered the sale process with much of the infrastructure buyers need to evaluate a medical-products platform with confidence already in place.

A Growing Market at the Intersection of Therapy and Technology

The transaction closed against a backdrop of sustained growth in pediatric speech therapy and communication-health technology. Demand is supported by a large recurring patient population and by increasing adoption of tools that blend hands-on therapy, digital resources, and teletherapy.

Funding is diversified across schools, self-pay families, and insurance, while adjacent opportunities in language learning, accent reduction, and other communication-support categories create additional room for specialized therapy platforms to expand beyond their core pediatric market.

Five Takeaways for Healthcare & Medical-Products Business Owners

Thinking About Selling Your Healthcare, Medical Products, or Therapy Company?

Speech Buddies' story shows what is possible when protected intellectual property, documented systems, and a strong mission are matched with the right strategic buyer. Sunbelt Atlanta advises owners of privately held companies through confidential sale processes with no upfront fees.

Helping Business Owners Navigate Successful Transitions Since 1998

Since 1998, Sunbelt Atlanta has helped business owners across Georgia and the Southeast sell their companies confidentially and on their own terms. With more than 1,250 businesses sold, a no-upfront-fee, success-driven approach, and experience across industries including healthcare technology and medical products, Sunbelt Atlanta's Dealmakers guide owners through every stage of a sale, from valuation through closing.

Owners of healthcare, medical-device, medical-products, and therapy companies who are considering a sale, whether now or a few years down the road, are welcome to begin with a confidential conversation about their options.